|
|
| | Mabuterolhydrochloride Basic information |
| Product Name: | Mabuterolhydrochloride | | Synonyms: | Broncholin (tn);D01589;Mabuterol hydrochloride (jan);Mabuterol hydrochloride solution,100ppm;MabuterolHCl;Benzenemethanol, 4-amino-3-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)-, monohydrochloride (9CI);Broncholin;dl-Mabuterol hydrochloride | | CAS: | 54240-36-7 | | MF: | C13H18ClF3N2O.HCl | | MW: | 347.2 | | EINECS: | | | Product Categories: | API | | Mol File: | 54240-36-7.mol |  |
| | Mabuterolhydrochloride Chemical Properties |
| Melting point | 205-206 °C | | solubility | Chloroform (Slightly, Heated, Sonicated), DMSO (Slightly, Sonicated), Methanol (Slightly) | | Stability: | Hygroscopic |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 | | HS Code | 29221990 | | Toxicity | dog,LD50,intravenous,27500ug/kg (27.5mg/kg),BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLDLUNGS, THORAX, OR RESPIRATION: DYSPNEA,Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984. |
| | Mabuterolhydrochloride Usage And Synthesis |
| Description | Mabuterol hydrochloride i s a β2-selective adrenergic agonist closely related to clenbuterol, and useful in the treatment of chronic bronchial asthma, bronchitis, and emphysema. Its oral potency and duration of action are reported to exceed
those of salbutamol. | | Originator | Dr. Karl Thomae (W. Germany) | | Uses | Mabuterol Hydrochloride is an acidic salt of Mabuterol (M104000). Mabuterol is a β2-adrenergic agonist, used as a bronchodilator/antiasthmatic. | | Definition | ChEBI: Mabuterol hydrochloride is a member of (trifluoromethyl)benzenes. | | Brand name | BRONCHOLIN |
| | Mabuterolhydrochloride Preparation Products And Raw materials |
|